WebApr 6, 2024 · 4 equities research analysts have issued 1-year price objectives for Gracell Biotechnologies' stock. Their GRCL share price forecasts range from $7.00 to $20.00. On average, they predict the company's stock price to reach $12.20 in the next year. This suggests a possible upside of 548.9% from the stock's current price. WebNov 28, 2024 · Date range: 1 August 2024 - 31 July 2024 No articles found. Gracell Biotechnologies (Shanghai) Co., Ltd. did not contribute to any primary research papers from Nature Index journals in the current ...
CAR-T Cell Therapy Market is expected to exceed $XX Mn
WebMar 13, 2024 · Gracell Biotechnologies to Report Fourth Quarter 2024 Financials on Monday, March 13, 2024. SAN DIEGO, Calif. , and SUZHOU and SHANGHAI, China , Feb. 27, 2024 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell " or the "C om pany"), a global clinical-stage biopharmaceutical company dedicated to … WebJun 2, 2024 · Gracell Biotechnology Ltd. Investigators. Layout table for investigator information; Principal Investigator: Peihua Lu, PhD&MD: Hebei Yanda Ludaopei Hospital: More Information. Go to Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More … data masking in oracle fusion
Gracell Biotechnologies Signs Agreement with Lonza to …
WebFeb 26, 2024 · Gracell addresses the issues of complex manufacture and high cost of cellular gene therapeutics. SUZHOU and SHANGHAI, China, Feb. 26, 2024 /PRNewswire/ -- Gracell Biotechnologies, Co., Ltd. ("Gracell") announced the completion of its $85 million series B funding today. The financing was led by Temasek with Lilly Asia Ventures, … WebMay 3, 2024 · Lastly, the market research report provides a regional comparison and a complete country-level analysis for the latest trends, along with the major key players (Gilead Sciences, Novartis AG, Gracell Biotechnology Ltd, Aeon Therapeutics, CARsgen Therapeutics, Daiichi Sankyo, Celegne, Otsuka Pharmaceutical, Biocon, Ono … WebDec 21, 2024 · Gracell Biotechnology Evaluate Home Vantage Pharmaceutical Companies Gracell Biotechnology December 21, 2024 Remarkably, interest in BCMA continues But, as Celyad bows out, how do you compete in a field as crowded as this? December 15, 2024 Ash 2024 roundup Evaluate Vantage's coverage of the Ash 2024 … bits and pieces free catalog request